首页 › 基金 › Propel Bio Management, LLC › UPB

Propel Bio Management, LLC 对 UPB 的持仓历史

UPSTREAM BIO INC · 医疗保健

Propel Bio Management, LLC 在 Q3 2026 的 13F 申报中披露持有 UPB(UPSTREAM BIO INC)335,389 股,市值约 US$1.8M,约占其申报组合的 0.94%,在其申报持仓中市值排名第 26 位。 Propel Bio Management, LLC 最近 3 个申报季度中有 3 个季度披露了 UPB 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q3 2026)335.39K 股
申报持仓市值$1.77M
组合权重0.94%
首次申报Q1 2026
最近变动减持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Propel Bio Management, LLC 对 UPB 的持仓演变

Propel Bio Management, LLC 于 Q1 2026 首次披露 UPB 持仓:341,779 股(约 US$3.1M)。 在 3 次申报中,Propel Bio Management, LLC 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 335,389 股、市值约 US$1.8M,环比减持 -15,000 股。。

逐季持仓明细

季度股数金额变化
Q1 2026 341.78K $3.10M 新进
Q2 2026 350.39K $2.42M 增持
Q3 2026 335.39K $1.77M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 UPB 与 13F 数据

UPB(UPSTREAM BIO INC)属于医疗保健行业。我们追踪的基金中还有 50 只申报持有 UPB,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$39.4M), Decheng Capital LLC (US$18.9M), Enavate Sciences GP, LLC (US$17.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 UPB 的基金

查看 UPB 的全部基金持有人 →

常见问题

How long has Propel Bio Management, LLC held UPB?

Propel Bio Management, LLC has disclosed UPB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Propel Bio Management, LLC's current position in UPB?

As of Q3 2026, Propel Bio Management, LLC holds 335.39K shares of UPB (UPSTREAM BIO INC), valued at $1.77M, representing 0.94% of its reported portfolio and ranking #26.

Has Propel Bio Management, LLC been buying or selling UPB?

In the latest 13F filing (Q3 2026), Propel Bio Management, LLC reduced its position in UPB.

Which other funds hold UPB?

Other major institutional holders of UPB include ORBIMED ADVISORS LLC, Decheng Capital LLC, Enavate Sciences GP, LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.